JRJian-Dong Ren

Jian-Dong Ren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jian-Dong Ren has a total of 48 co-authors. Here are the top co-authors by number of shared publications:

  • Zhu-Lin Luo

    People's Liberation Army The General Hospital of Western Theater Command

    5 shared publications
  • Long Cheng

    General Surgery Center of PLA, the General Hospital of Western Theater Command, Chengdu 610083, China

    4 shared publications
  • Wen-Qi He

    Department of Pharmacy, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China; Innovation Center of Advanced Pharmaceutical & Artificial Intelligence, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610054, China

    3 shared publications
  • Xiao-Bo Wu

    Department of Ultrasound, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Chengdu 610041, China

    3 shared publications
  • Ying-Rui Tang

    Department of Pharmacy, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China; Xichang Medical College, Xichang 615000, China

    3 shared publications
  • Hong-Yu Sun

    Central Laboratory, the General Hospital of Western Theater Command, Chengdu 610083, China

    2 shared publications

Latest Publications

  • Open Access

    Kupffer Cell–Derived Exosomal S100A8/A9 Promotes Inflammasome–Dependent Pyroptotic Lung Injury in Acute Pancreatitis

    by Wen-Qi He, Yi Liu, Ying-Rui Tang, Rui Wang, Chang-Ping Chen, Xiao-Qin Lv, Yuan-Fei Sha, Jian-Dong Ren


  • Open Access

    Artificial Intelligence in Medicinal Herb Breeding

    by Biyu Hou, Caiyan Liang, Xiao Sheng, YongGuo Liu, JianDong Ren, Qiang Ma, Tengjiao Wang, Lei Zhang


  • Heparan sulfate acts as an activator of the NLRP3 inflammasome promoting inflammatory response in the development of acute pancreatitis

    by Li-Jun Zhao, Peng Chen, Ling Huang, Wen-Qi He, Ying-Rui Tang, Rui Wang, Zhu-Lin Luo, Jian-Dong Ren

    Background Accumulating evidence has shown that the NOD-like receptor protein 3 (NLRP3) inflammasome plays a crucial role in the inflammatory cascades involved in the development of acute pancreatitis (AP). However, the specific agonist responsible for activating the NLRP3 inflammasome in this process has not yet been identified. The purpose of this study is to clarify whether heparan sulfate (HS) works as an NLRP3 inflammasome activator to evoke inflammatory cascades in the progression of AP. Methods Two experimental mouse models of AP were utilized to investigate the pro-inflammatory activity of HS in the development of AP by measuring the secretion of inflammatory cytokines and the neutrophil infiltration in pancreatic tissue. The ability of HS to activate the NLRP3 inflammasome was evaluated both in vitro and in vivo. The nuclear factor kappa B (NF-κB)-mediated expression of NLRP3 inflammasome components in response to HS treatment was determined to decipher the role of HS in transcriptional priming of NLRP3 inflammasome. Furthermore, HS-triggered deubiquitination of NLRP3 was analyzed to reveal the promoting effect of HS on the NLRP3 inflammasome priming via a non-transcriptional pathway. Results High plasma level of HS was observed with a positive correlation to that of inflammatory cytokines in AP mice. Administration of HS to mice resulted in an exacerbated inflammatory profile, while reducing HS production by an inhibitor of heparanase significantly attenuated inflammatory response. Pharmacological inhibition or genetic deletion of NLRP3 substantially suppressed the HS-stimulated elevation of IL-1β levels in AP mice. The in vitro data demonstrated that HS primarily serves as a priming signal for the activation of the NLRP3 inflammasome. HS possesses the ability to increase the transcriptional activity of NF-κB and TLR4/NF-κB-driven transcriptional pathway is employed for NLRP3 inflammasome priming. Moreover, HS-induced deubiquitination of NLRP3 is another pathway responsible for non-transcriptional priming of NLRP3 inflammasome. Conclusions Our current work has unveiled HS as a new activator of the NLRP3 inflammasome responsible for the secondary inflammatory cascades during the development of AP, highlighting the HS-NLRP3 pathway as a potential target for future preventive and therapeutic approaches of AP.


  • Nafamostat mesilate prevented caerulein-induced pancreatic injury by targeting HDAC6-mediated NLRP3 inflammasome activation

    by Peng Chen, Li-Jun Zhao, Ling Huang, Wen-Qi He, Ying-Rui Tang, Yi Liu, Jian-Dong Ren

    Objective Nafamostat mesilate (NM), a synthetic broad-spectrum serine protease inhibitor, has been commonly used for treating acute pancreatitis (AP) and other inflammatory-associated diseases in some East Asia countries. Although the potent inhibitory activity against inflammation-related proteases (such as thrombin, trypsin, kallikrein, plasmin, coagulation factors, and complement factors) is generally believed to be responsible for the anti-inflammatory effects of NM, the precise target and molecular mechanism underlying its anti-inflammatory activity in AP treatment remain largely unknown. Methods The protection of NM against pancreatic injury and inhibitory effect on the NOD-like receptor protein 3 (NLRP3) inflammasome activation were investigated in an experimental mouse model of AP. To decipher the molecular mechanism of NM, the effects of NM on nuclear factor kappa B (NF-κB) activity and NF-κB mediated NLRP3 inflammasome priming were examined in lipopolysaccharide (LPS)-primed THP-1 cells. Additionally, the potential of NM to block the activity of histone deacetylase 6 (HDAC6) and disrupt the association between HDAC6 and NLRP3 was also evaluated. Results NM significantly suppressed NLRP3 inflammasome activation in the pancreas, leading to a reduction in pancreatic inflammation and prevention of pancreatic injury during AP. NM was found to interact with HDAC6 and effectively inhibit its function. This property allowed NM to influence HDAC6-dependent NF-κB transcriptional activity, thereby blocking NF-κB-driven transcriptional priming of the NLRP3 inflammasome. Furthermore, NM exhibited the potential to interfere the association between HDAC6 and NLRP3, impeding HDAC6-mediated intracellular transport of NLRP3 and ultimately preventing NLRP3 inflammasome activation. Conclusions Our current work has provided valuable insight into the molecular mechanism underlying the immunomodulatory effect of NM in the treatment of AP, highlighting its promising application in the prevention of NLRP3 inflammasome-associated inflammatory pathological damage.


  • Open Access

    Protective effects of epigallocatechin-3-gallate against ultraviolet radiation caused keratinocyte injury: targeting the NLRP3 inflammasome priming and activation

    by Zhu-Lin Luo, Qi-Xiong Zhang, Min Du, Qian Wang, Yi Liu, Jian-Dong Ren

    Inflammatory response occurring after ultraviolet (UV) exposure is regarded as one of the major causes of skin photodamage. As a crucial mediator of inflammatory cascades, the NOD-like receptor protein 3 (NLRP3) inflammasome has been reported to be responsible for UV radiation (UVR) evoked inflammation in keratinocytes, emerging as a promising target for therapeutic intervention. Epigallocatechin-3-gallate (EGCG), the most abundant polyphenol in green tea, has been found to afford protection against UVR-caused keratinocyte injury, but mechanism clarifying its precise target still awaits further exploration. The aim of this study was to examine whether EGCG had the ability to inhibit UVR-triggered NLRP3 inflammasome activation in keratinocytes which accounted for the protection against cell damage. The results showed EGCG prevented HaCaT cells from UVR-induced DNA insults by counteracting oxidative stress and inflammatory cytokines production. NLRP3 inflammasome activation in response to UVR was markedly suppressed by EGCG. Moreover, EGCG inhibited the induction of new mtDNA synthesis by downregulating the expression of IRF-1, CMPK2 and phosphorylated STAT1. Meanwhile, EGCG reduced the excessive production of mitochondrial reactive oxygen species (mtROS) and ox-mtDNA in UV-exposed cells so that both deubiquitination of NLRP3 and the binding of ox-mtDNA to NLRP3 were suppressed, resulting in impaired NLRP3 inflammasome priming and activation. Our results have identified the potent activity of EGCG to ameliorate NLRP3 inflammasome-driven photodamage in keratinocytes caused by UVR. Apart from the mtROS-scavenging activity which enabled EGCG to antagonize mtROS-triggered NLRP3 inflammasome activation, a novel antioxidation-independent mechanism of EGCG in NLRP3 inhibition was revealed.

  • Epigallocatechin-3-gallate attenuates acute pancreatitis induced lung injury by targeting mitochondrial reactive oxygen species triggered NLRP3 inflammasome activation

    by Zhu-Lin Luo, Hong-Yu Sun, Xiao-Bo Wu, Long Cheng, Jian-Dong Ren

    Green tea has been considered as a health-promoting beverage and is widely consumed worldwide. Epigallocatechin-3-gallate (EGCG), the most abundant polyphenol derived from green tea leaves with potent antioxidative and chemopreventive activities, has been reported to offer protection against inflammation-driven tissue damage. Here, we evaluated the protective effects of EGCG against lung injury during acute pancreatitis (AP) and further revealed the detailed mechanism. The results showed that EGCG significantly attenuated L-arginine-induced AP and the consequent pulmonary damage in mice. Moreover, EGCG substantially attenuated oxidative stress and concurrently suppressed NOD-like receptor protein 3 (NLRP3) inflammasome activation in the lung. In vitro, EGCG considerably reduced the production of mitochondrial reactive oxygen species (mtROS) and oxidized mitochondrial DNA (ox-mtDNA) in alveolar macrophages (AMs) challenged with AP-conditioned plasma. Meanwhile, the amount of ox-mtDNA bound to NLRP3 decreased significantly by the treatment with EGCG, resulting in impaired NLRP3 inflammasome activation. In addition, the antagonism of NLRP3 signaling by EGCG was affected in the presence of the mtROS stimulant rotenone or scavenger Mito-TEMPO. Altogether, EGCG possesses potent activity to attenuate lung injury during AP progression by inhibiting NLRP3 inflammasome activation. As for the mechanism, the EGCG-conferred restriction of NLRP3 inflammasome activation probably arises from the elimination of mtROS as well as its oxidative product ox-mtDNA, which consequently enables the protection against AP-associated lung injury.


  • Open Access

    The Role of Exogenous Hydrogen Sulfide in Free Fatty Acids Induced Inflammation in Macrophages

    by Zhu-Lin Luo, Jian-Dong Ren, Zhu Huang, Tao Wang, Ke Xiang, Long Cheng, Li-Jun Tang

    Background: This study aimed to investigate whether exogenous hydrogen sulfide (H2S) can protect the RAW264.7 macrophages against the inflammation induced by free fatty acids (FFA) by blunting NLRP3 inflammasome activation via a specific TLR4/NF-κB pathway. Methods: RAW264.7 macrophages were exposed to increasing concentrations of FFA for up to 3 days to induce FFA-induced inflammation. The cells were pretreated with NaHS (a donor of H2S) before exposure to FFA. Cell viability, cell apoptosis, TLR4, NF-κB, NLRP3 inflammasome, IL-1β, IL-18 and cleaved caspase-3 expression were measured by a combination of MTT assay, ELISA, and immunoblotting. Results: H2S attenuated FFA-induced cell apoptosis, and reduced the expression of NLRP3, ASC, pro-caspase-1, caspase-1, IL- 1β, IL-18 and caspase-3. In addition, H2S inhibited the FFA-induced activation of TLR4 and NF-κB. Furthermore, NLRP3 inflammasome activation was regulated by the TLR4 and NF-κB pathway. Conclusion: The present study demonstrated for the first time that H2S appears to suppress FFA-induced macrophage inflammation and apoptosis by inhibiting the TLR4/ NF-κB pathway and its downstream NLRP3 inflammasome activation. Thus H2S might possess potential in the treatment of diseases resulting from FFA overload like insulin resistance and type diabetes.


  • Open Access

    Hydrogen‐Rich Saline Protects against Ischemia/Reperfusion Injury in Grafts after Pancreas Transplantations by Reducing Oxidative Stress in Rats

    by Zhu-Lin Luo, Long Cheng, Jian-Dong Ren, Chen Fang, Ke Xiang, Hao-Tong Xu, Li-Jun Tang, Tao Wang, Fu-Zhou Tian

    Purpose. This study aimed to investigate the therapeutic potential of hydrogen‐rich saline on pancreatic ischemia/reperfusion (I/R) injury in rats. Methods. Eighty heterotopic pancreas transplantations (HPT) were performed in syngenic rats. The receptors were randomized blindly into the following three groups: the HPT group and two groups that underwent transplantation and administration of hydrogen‐rich saline (HS, >0.6 mM, 6 mL/kg) or normal saline (NS, 6 mL/kg) via the tail vein at the beginning of reperfusion (HPT + HS group, HPT + NS group). Samples from the pancreas and blood were taken at 12 hours after reperfusion. The protective effects of hydrogen‐rich saline against I/R injury were evaluated by determining the changes in histopathology and measuring serological parameters, oxidative stress‐associated molecules, and proinflammatory cytokines. Results. Administration of hydrogen‐rich saline produced notable protection against pancreatic I/R injury in rats. Histopathological improvements and recovery of impaired pancreatic function were observed. In addition, TNF‐α, IL‐1β, and IL‐6 were reduced markedly in the HPT + HS group. Additionally, there were noticeable inhibitory effects on the pancreatic malondialdehyde level and considerable recruitment of SOD and GPx, which are antioxidants. Conclusion. Hydrogen‐rich saline treatment significantly attenuated the severity of pancreatic I/R injury in rats, possibly by reducing oxidative stress and inflammation.